These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19808245)

  • 1. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study.
    Navarro-González JF; Mora-Fernández C; Muros M; Herrera H; García J
    Clin J Am Soc Nephrol; 2009 Oct; 4(10):1646-54. PubMed ID: 19808245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
    Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate.
    Muntner P; Jones TM; Hyre AD; Melamed ML; Alper A; Raggi P; Leonard MB
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):186-94. PubMed ID: 19019998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
    Levin A; Bakris GL; Molitch M; Smulders M; Tian J; Williams LA; Andress DL
    Kidney Int; 2007 Jan; 71(1):31-8. PubMed ID: 17091124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related with the progression of chronic kidney disease.
    Yuste C; Barraca D; Aragoncillo-Sauco I; Vega-Martínez A; Abad S; Verdalles-Guzmán Ú; Ruiz-Caro C; Ampuero J; López-Gómez JM
    Nefrologia; 2013; 33(5):685-91. PubMed ID: 24089160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old.
    Van Pottelbergh G; Vaes B; Jadoul M; Matheï C; Wallemacq P; Degryse JM
    Arch Gerontol Geriatr; 2012; 54(3):e419-25. PubMed ID: 22265240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
    Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
    Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
    Wahl P; Xie H; Scialla J; Anderson CA; Bellovich K; Brecklin C; Chen J; Feldman H; Gutierrez OM; Lash J; Leonard MB; Negrea L; Rosas SE; Anderson AH; Townsend RR; Wolf M; Isakova T;
    Diabetes Care; 2012 May; 35(5):994-1001. PubMed ID: 22446176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Vassalotti JA; Uribarri J; Chen SC; Li S; Wang C; Collins AJ; Calvo MS; Whaley-Connell AT; McCullough PA; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S56-68. PubMed ID: 18359409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness.
    Andrade J; Er L; Ignaszewski A; Levin A
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1800-6. PubMed ID: 18922995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
    Shaheen FA; Kurpad R; Al-Sayyari AA; Souqiyyeh MZ; Aljubori H; El Baz T; Kashif W; Tuganbekova S; Kabulbayev K; Jarraya F; Nafar M
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):290-304. PubMed ID: 26997382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
    Block GA; Hulbert-Shearon TE; Levin NW; Port FK
    Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.
    Wang WH; Chen LW; Lee CC; Sun CY; Shyu YC; Hsu HR; Chien RN; Wu IW
    Biomed Res Int; 2017; 2017():7435657. PubMed ID: 28367447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.